Holz FG - Search Results

1

The role of the complement system in age-related macular degeneration.

Weber BH, Charbel Issa P, Pauly D, Herrmann P, Grassmann F, Holz FG. Weber BH, et al. Among authors: holz fg. Dtsch Arztebl Int. 2014 Feb 21;111(8):133-8. doi: 10.3238/arztebl.2014.0133. Dtsch Arztebl Int. 2014. PMID: 24622760 Free PMC article. Review.

2

Kjellin's syndrome: fundus autofluorescence, angiographic, and electrophysiologic findings.

Frisch IB, Haag P, Steffen H, Weber BH, Holz FG. Frisch IB, et al. Among authors: holz fg. Ophthalmology. 2002 Aug;109(8):1484-91. doi: 10.1016/s0161-6420(02)01110-7. Ophthalmology. 2002. PMID: 12153800

3

Pathogenesis of lesions in late age-related macular disease.

Holz FG, Pauleikhoff D, Klein R, Bird AC. Holz FG, et al. Am J Ophthalmol. 2004 Mar;137(3):504-10. doi: 10.1016/j.ajo.2003.11.026. Am J Ophthalmol. 2004. PMID: 15013875 Review.

4

Keypathophysiologic pathways in age-related macular disease.

Roth F, Bindewald A, Holz FG. Roth F, et al. Among authors: holz fg. Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):710-6. doi: 10.1007/s00417-004-0976-x. Epub 2004 Aug 10. Graefes Arch Clin Exp Ophthalmol. 2004. PMID: 15309554 Review.

5

Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration.

Schmitz-Valckenberg S, Bültmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K. Schmitz-Valckenberg S, et al. Among authors: holz fg. Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4470-6. doi: 10.1167/iovs.03-1311. Invest Ophthalmol Vis Sci. 2004. PMID: 15557456

6

New pharmacologic approaches to therapy for age-related macular degeneration.

Eter N, Krohne TU, Holz FG. Eter N, et al. Among authors: holz fg. BioDrugs. 2006;20(3):167-79. doi: 10.2165/00063030-200620030-00004. BioDrugs. 2006. PMID: 16724865 Review.

7

Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration.

Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP, Schmitz-Valckenberg S; FAM-Study Group. Holz FG, et al. Am J Ophthalmol. 2007 Mar;143(3):463-72. doi: 10.1016/j.ajo.2006.11.041. Epub 2006 Dec 22. Am J Ophthalmol. 2007. PMID: 17239336

8

An update on the genetics of age-related macular degeneration.

Scholl HP, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BH. Scholl HP, et al. Among authors: holz fg. Mol Vis. 2007 Feb 7;13:196-205. Mol Vis. 2007. PMID: 17327825 Free PMC article. Review.

9

Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia.

Charbel Issa P, Helb HM, Rohrschneider K, Holz FG, Scholl HP. Charbel Issa P, et al. Among authors: holz fg. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3788-95. doi: 10.1167/iovs.06-1272. Invest Ophthalmol Vis Sci. 2007. PMID: 17652753

10

Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.

Ladewig MS, Karl SE, Hamelmann V, Helb HM, Scholl HP, Holz FG, Eter N. Ladewig MS, et al. Among authors: holz fg. Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):17-25. doi: 10.1007/s00417-007-0654-x. Epub 2007 Aug 15. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17701197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

854 results

Search Page